Sunday, February 22

Healthcare

COSCIENS Biopharma crashes on trial setback for lead asset

08/28/20241 Min Read

asset biopharma COSCIENS crashes lead setback trial

Previous ArticleSpain and Germany to donate mpox vaccine doses to Africa

Next Article Inspire Veterinary Partners to acquire Vetsie.ai